Positron emission tomography for predicting malignancy of sinonasal inverted papilloma

Clinical Nuclear Medicine

Volumn 32, Issue 4, 2007, Pages 275-278

  Shojaku, Hideo ^a   Fujisaka, Michiro ^a   Yasumura, Satsuki ^a   Ishida, Masayuki ^a   Tsubota, Masahito ^a   Nishida, Hiroshi ^a   Watanabe, Yukio ^a   Kawano, Masaya ^b   Shimizu, Masashi ^a   Fukuoka, Jyunya ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANAZAWA CARDIOVASCULAR HOSPITAL   (Japan)

Author keywords

Associated squamous cell carcinoma; Case report; Diagnosis; FDG PET; Human; Inverted papilloma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG UPTAKE; FEMALE; HUMAN; HUMAN TISSUE; MALE; NOSE POLYP; PAPILLOMA; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SQUAMOUS CELL CARCINOMA; TUMOR BIOPSY;

AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PAPILLOMA, INVERTED; PARANASAL SINUS NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 34147130297     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rlu.0000257334.65253.cc     Document Type: Article

References (18)

1. Lampertico P, Russel WO, MacComb WS. Squamous papilloma of the upper respiratory epithelium. Arch Pathol Lab Med. 1963;7:293-302.
2. Ringertz N. Pathology of malignant tumors arising in the nasal and paranasal sinus cavities and maxilla. Acta Otolaryngol. 1938;27(Suppl):31-42.
3. Hyams DJ. Papillomas of the nasal cavity and paranasal simuses. Ann Otol Shonol Laryngol. 1971;80:192-206.
4. Kelly JH, Joseph M, Carrol E, et al. Inverted papilloma of the nasal septum. Arch Otolaryngol. 1980;767-771.
5. Lawson W, Lathanger J, Som P, et al. Inverted pappilloma: analysis of 87 cases. Laryngoscope. 1989;99:117-124.
6. Furuta Y, Shonohara T, Sano K. Molecular pathologic study of human papillomavirus infection in inverted papilloma and squamous cell carcinoma of the nasal cavities and paranasal sinuses. Laryngoscope. 1991;101:79-85.
7. Myers EN, Fernau JL, Johnson JT, et al. Management of inverted papilloma. Laryngoscope. 1990;100:481-490.
8. Schoeder H, Yeung HWD. Positron emission imaging of head and neck cancer, including thyroid carcinoma. Semin Nucl Med. 2004;34:180-197.
9. Warburg O. The Metabolism of Tumors. London: Arnold Constable, 1930:75-327.
10. Bakheet SM, Powe J. Benign cases of 18-FDG uptake on whole body imaging. Semin Nucl Med. 1998;28:352-358.
11. Sugawara Y, Zasadny KR, Neuhoff AW, et al. Reevaluation of the standardized uptake value for FDG; variations with body weight and methods for correction. Radiology. 1999;21:521-525.
12. Sugawara Y, Zasadny KR, Neuhoff AW, et al. Reevaluation of standatized uptake value of FDG: variations with body wight and methods for correction. Radiology. 1999;21:521-525.
13. Barnes L, Tse LLY, Hunt JL. Schneidrian papillomas. In: Barnes L, Eveson JW, Reichert P, et al, eds. World Health Organization Classification of Tumours. Pathology and Genetics of Head and Neck Tumours. Lyon: ARC Press, 2005:28-32.
14. Stokkel MPM, Bongers V, Hordijk G-J, et al. FDG positron emission tomography in head and neck cancer. Pitfall or pathology? Clin Nucl Med. 1999;24:950-954.
15. Sakamoto H, Naka Y, Ohashi Y, et al. Positron emission tomographic imaging of head and neck lesions. Eur Arch Otohinolaryngol. 1997;254(Suppl 1):S12-S126.
16. Tanaka R, Emerson LL, Karwande SV, et al. Growing pulmonary nodule with increased 18-fluorodeoxyglucose uptake in a former smoker. Chest. 2005;127:1848-1851.
17. Sunada I, Tsuyuguchi N, Hara M, et al. 18F-FDG and 11C-Methionine PET in choroid plexux papilloma - report of three cases. Rad Med. 2002;20:97-100.
18. Barnes L, Vervin RS, Gnepp DR. Diseases of the nose, paranasal sinuses, and nasopharynx. In: Barnes L, ed. Surgical Pathology of the Head and Neck. vol 1. New York: Marcel Deker, 1985:403-451.